Trial Profile
Predicting the bronchoprotective response to a leukotriene modifier by genetic polymorphism
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Asthma
- Focus Biomarker; Therapeutic Use
- 05 Nov 2005 New trial record.